Insider · CIK 0001379459

Chappell Dale

Reports to the SEC for 6 companies · CHARLOTTE, NC

sec.gov

Transactions

Companies

Filings

CIK

0001379459

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-10-18	HUMANIGEN, INCS Sale	Director, Chief Scientific Officer, 10% Owner	SSale	−276K sh	$0.01	−$3,038.31	8,398,871
2023-10-18	HUMANIGEN, INCS Sale	Director, Chief Scientific Officer, 10% Owner	SSale	−34.3K sh	$0.01	−$376.783	1,041,536
2023-10-18	HUMANIGEN, INCS Sale	Director, Chief Scientific Officer, 10% Owner	SSale	−75.9K sh	$0.01	−$834.757	2,307,530
2022-07-27	HUMANIGEN, INCStock Option (Right to Buy)A Award	Director, Chief Scientific Officer, 10% Owner	AAward	+518K sh	—	—	518,205
2022-05-20	HUMANIGEN, INCP Purchase	Director, Chief Scientific Officer, 10% Owner	PPurchase	+382K sh	$2.23	+$851K	8,675,081
2022-05-20	HUMANIGEN, INCP Purchase	Director, Chief Scientific Officer, 10% Owner	PPurchase	+109K sh	$2.23	+$243K	2,383,417
2022-05-20	HUMANIGEN, INCP Purchase	Director, Chief Scientific Officer, 10% Owner	PPurchase	+54.5K sh	$2.23	+$122K	1,075,789
2022-05-19	HUMANIGEN, INCP Purchase	Director, Chief Scientific Officer, 10% Owner	PPurchase	+32.4K sh	$2.19	+$70.8K	1,021,240
2022-05-19	HUMANIGEN, INCP Purchase	Director, Chief Scientific Officer, 10% Owner	PPurchase	+64.8K sh	$2.19	+$142K	2,274,319
2022-05-19	HUMANIGEN, INCP Purchase	Director, Chief Scientific Officer, 10% Owner	PPurchase	+227K sh	$2.19	+$495K	8,293,240
2022-05-18	HUMANIGEN, INCP Purchase	Director, Chief Scientific Officer, 10% Owner	PPurchase	+34.7K sh	$1.96	+$68.2K	2,209,557
2022-05-18	HUMANIGEN, INCP Purchase	Director, Chief Scientific Officer, 10% Owner	PPurchase	+122K sh	$1.96	+$239K	8,066,575
2022-05-18	HUMANIGEN, INCP Purchase	Director, Chief Scientific Officer, 10% Owner	PPurchase	+17.4K sh	$1.96	+$34.1K	988,859
2022-03-11	HUMANIGEN, INCP Purchase	Director, Chief Scientific Officer, 10% Owner	PPurchase	+700K sh	$3.00	+$2.1M	7,944,985
2022-03-11	HUMANIGEN, INCP Purchase	Director, Chief Scientific Officer, 10% Owner	PPurchase	+100K sh	$3.00	+$300K	971,489
2022-03-11	HUMANIGEN, INCP Purchase	Director, Chief Scientific Officer, 10% Owner	PPurchase	+200K sh	$3.00	+$600K	2,174,817
2022-03-10	HUMANIGEN, INCCall Option (Right to Buy)P Purchase	Director, Chief Scientific Officer, 10% Owner	PPurchase	+157 sh	$0.75	+$117.75	818
2022-03-10	HUMANIGEN, INCCall Option (Right to Buy)P Purchase	Director, Chief Scientific Officer, 10% Owner	PPurchase	+550 sh	$0.75	+$412.5	2,866
2022-03-10	HUMANIGEN, INCCall Option (Right to Buy)P Purchase	Director, Chief Scientific Officer, 10% Owner	PPurchase	+79 sh	$0.75	+$59.25	410
2022-03-09	HUMANIGEN, INCCall Option (Right to Buy)P Purchase	Director, Chief Scientific Officer, 10% Owner	PPurchase	+293 sh	$0.79	+$230.591	661
2022-03-09	HUMANIGEN, INCCall Option (Right to Buy)P Purchase	Director, Chief Scientific Officer, 10% Owner	PPurchase	+5 sh	$1.20	+$6	1,055
2022-03-09	HUMANIGEN, INCCall Option (Right to Buy)P Purchase	Director, Chief Scientific Officer, 10% Owner	PPurchase	+36 sh	$1.20	+$43.2	7,393
2022-03-09	HUMANIGEN, INCCall Option (Right to Buy)P Purchase	Director, Chief Scientific Officer, 10% Owner	PPurchase	+147 sh	$0.79	+$115.689	331
2022-03-09	HUMANIGEN, INCCall Option (Right to Buy)P Purchase	Director, Chief Scientific Officer, 10% Owner	PPurchase	+1,026 sh	$0.79	+$807.462	2,316
2022-03-09	HUMANIGEN, INCCall Option (Right to Buy)P Purchase	Director, Chief Scientific Officer, 10% Owner	PPurchase	+10 sh	$1.20	+$12	2,111
2022-03-08	HUMANIGEN, INCCall Option (Right to Buy)P Purchase	Director, Chief Scientific Officer, 10% Owner	PPurchase	+476 sh	$1.20	+$571.2	2,101
2022-03-08	HUMANIGEN, INCCall Option (Right to Buy)P Purchase	Director, Chief Scientific Officer, 10% Owner	PPurchase	+238 sh	$1.20	+$285.6	1,050
2022-03-08	HUMANIGEN, INCCall Option (Right to Buy)P Purchase	Director, Chief Scientific Officer, 10% Owner	PPurchase	+1,668 sh	$1.20	+$2,001.6	7,357
2022-03-04	HUMANIGEN, INCCall Option (Right to Buy)P Purchase	Director, Chief Scientific Officer, 10% Owner	PPurchase	+127 sh	$0.90	+$113.944	812
2022-03-04	HUMANIGEN, INCCall Option (Right to Buy)P Purchase	Director, Chief Scientific Officer, 10% Owner	PPurchase	+891 sh	$0.90	+$799.405	5,689
2022-03-04	HUMANIGEN, INCCall Option (Right to Buy)P Purchase	Director, Chief Scientific Officer, 10% Owner	PPurchase	+255 sh	$0.90	+$228.786	1,625
2022-03-03	HUMANIGEN, INCCall Option (Right to Buy)P Purchase	Director, Chief Scientific Officer, 10% Owner	PPurchase	+346 sh	$0.35	+$121.1	368
2022-03-03	HUMANIGEN, INCCall Option (Right to Buy)P Purchase	Director, Chief Scientific Officer, 10% Owner	PPurchase	+10 sh	$0.70	+$7	1,370
2022-03-03	HUMANIGEN, INCCall Option (Right to Buy)P Purchase	Director, Chief Scientific Officer, 10% Owner	PPurchase	+1,213 sh	$0.35	+$424.55	1,290
2022-03-03	HUMANIGEN, INCCall Option (Right to Buy)P Purchase	Director, Chief Scientific Officer, 10% Owner	PPurchase	+173 sh	$0.35	+$60.55	184
2022-03-03	HUMANIGEN, INCCall Option (Right to Buy)P Purchase	Director, Chief Scientific Officer, 10% Owner	PPurchase	+36 sh	$0.70	+$25.2	4,798
2022-03-03	HUMANIGEN, INCCall Option (Right to Buy)P Purchase	Director, Chief Scientific Officer, 10% Owner	PPurchase	+5 sh	$0.70	+$3.5	685
2022-03-02	HUMANIGEN, INCCall Option (Right to Buy)P Purchase	Director, Chief Scientific Officer, 10% Owner	PPurchase	+1,360 sh	$0.60	+$810.56	1,360
2022-03-02	HUMANIGEN, INCCall Option (Right to Buy)P Purchase	Director, Chief Scientific Officer, 10% Owner	PPurchase	+680 sh	$0.60	+$405.28	680
2022-03-02	HUMANIGEN, INCCall Option (Right to Buy)P Purchase	Director, Chief Scientific Officer, 10% Owner	PPurchase	+22 sh	$0.33	+$7.161	22
2022-03-02	HUMANIGEN, INCCall Option (Right to Buy)P Purchase	Director, Chief Scientific Officer, 10% Owner	PPurchase	+77 sh	$0.33	+$25.064	77
2022-03-02	HUMANIGEN, INCCall Option (Right to Buy)P Purchase	Director, Chief Scientific Officer, 10% Owner	PPurchase	+11 sh	$0.33	+$3.581	11
2022-03-02	HUMANIGEN, INCCall Option (Right to Buy)P Purchase	Director, Chief Scientific Officer, 10% Owner	PPurchase	+4,762 sh	$0.60	+$2,838.152	4,762
2022-01-12	HUMANIGEN, INCStock Option (Right to Buy)A Award	Director, Chief Scientific Officer, 10% Owner	AAward	+36.6K sh	—	—	36,550
2021-12-31	HUMANIGEN, INCStock Option (Right to Buy)A Award	Director, Chief Scientific Officer, 10% Owner	AAward	+44.6K sh	—	—	44,600
2021-09-30	HUMANIGEN, INCStock Option (Right to Buy)A Award	Director, Chief Scientific Officer, 10% Owner	AAward	+22.6K sh	—	—	22,626
2021-08-12	HUMANIGEN, INCS Sale	Director, Chief Scientific Officer, 10% Owner	SSale	−4,316 sh	$17.16	−$74.1K	873,693
2021-08-12	HUMANIGEN, INCS Sale	Director, Chief Scientific Officer, 10% Owner	SSale	−11.5K sh	$17.16	−$198K	1,980,696
2021-08-12	HUMANIGEN, INCS Sale	Director, Chief Scientific Officer, 10% Owner	SSale	−41.7K sh	$17.16	−$716K	7,266,296
2021-08-11	HUMANIGEN, INCS Sale	Director, Chief Scientific Officer, 10% Owner	SSale	−8,224 sh	$17.07	−$140K	878,009

Recent filings

Accepted (ET)
Oct 204
BLACK HORSE CAPITAL LP0001013594-23-000819
SEC(opens sec.gov)
Jul 294
Chappell Dale0001214659-22-009388
SEC(opens sec.gov)
May 204
BLACK HORSE CAPITAL LP0001013594-22-000446
SEC(opens sec.gov)
Mar 154
BLACK HORSE CAPITAL LP0001013594-22-000291
SEC(opens sec.gov)
Mar 104
BLACK HORSE CAPITAL LP0001013594-22-000276
SEC(opens sec.gov)

Companies

Address

338 S. SHARON AMITY RD., #202

CHARLOTTE, NC, 28211